University of San Diego

Digital USD
At Risk for Huntington's Disease

Department of History

3-1-2012

Top researcher: ‘Genuine optimism’ about treatments for
Huntington's disease
Kenneth P. Serbin
University of San Diego

Follow this and additional works at: https://digital.sandiego.edu/huntingtons
Part of the Nervous System Diseases Commons

Digital USD Citation
Serbin, Kenneth P., "Top researcher: ‘Genuine optimism’ about treatments for Huntington's disease"
(2012). At Risk for Huntington's Disease. 124.
https://digital.sandiego.edu/huntingtons/124

This Blog Post is brought to you for free and open access by the Department of History at Digital USD. It has been
accepted for inclusion in At Risk for Huntington's Disease by an authorized administrator of Digital USD. For more
information, please contact digital@sandiego.edu.

11/16/21, 2:13 PM

At Risk for Huntington's Disease: Top researcher: ‘Genuine optimism’ about treatments for Huntington’s disease

More

Create Blog

Sign In

At Risk for Huntington's Disease
HD is a genetically caused brain disorder that causes uncontrollable bodily movements and robs
people's ability to walk, talk, eat, and think. The final result is a slow, ugly death. Children of parents
with HD have a 50-50 chance of inheriting the disease. There is no cure or treatment.
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THURSDAY, MARCH 01, 2012

Top researcher: ‘Genuine optimism’ about
treatments for Huntington’s disease
With several potential treatments heading for clinical trials, the head
researcher of the so-called “cure Huntington’s initiative” feels “genuine
optimism” about alleviating the devastating symptoms of this incurable,
fatal brain disorder that also affects other areas of the body.
“People ask me all the time, ‘Are you optimistic?’” said Dr. Robert Pacifici,
the chief scientific officer of CHDI Management, Inc., the virtual biotech
firm dedicated exclusively to ending HD. “I am. I really am. I’m genuinely
optimistic.”
CHDI Management is the research arm of the CHDI Foundation, Inc., the
multi-million-dollar initiative backed by a group of anonymous donors.
Dr. Pacifici made his comments in an interview with me during CHDI’s 7th
Annual HD Therapeutics Conference at the Parker Palm Springs hotel in
Palm Springs, CA, February 27-March 1.
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Representing both academia and drug companies, the approximately 200
scientists and observers at the conference were abuzz with the promising
developments presented by their colleagues in the formal part of the
program.
When he expresses optimism, Dr. Pacifici told me, “the HD community
doesn’t let you get off easy. They say, ‘Why?”
He outlined three major reasons for his optimism.
First, CHDI and the HD research community have “a large number of
shots on goal” in terms of potential treatments.
“There are now eight things with the potential to reach the clinic in a twoyear time horizon and a bunch more behind that,” Dr. Pacifici said.
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(Scientists do not predict the outcomeof trials nor the date at which an
effective treatment will be found.)
Secondly, he stated that researchers will test each compound under study
so as to obtain “an unambiguous result.” This will permit the researchers
to quickly evaluate the results and, if necessary, adjust the compounds.
Third, Dr. Pacifici pointed out that the potential treatments are “customcrafted” for Huntington’s disease.
Researchers know that potential drugs must to enter the brain, be taken
for a long time, and not present serious negative side effects, he explained.
By making the drugs HD-specific, the researchers can meet these
challenges.
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Future articles will explore the results of the conference and specific
treatments in greater detail.
You can my watch the interview with Dr. Pacifici in the video below. Also
visit www.hdbuzz.net.
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2 comments:
Unknown said...
Great job Gene, this would be great to show at the support
group meeting. Liked the way you got Dr. Pacifici to explain in
common terms.
7:56 AM, March 02, 2012

Anonymous said...
Dear Sir .. I was very optimistic when I read this news .. But in
recent times read that Alnylam has moved back from RNAi
clinical trails .. Is there any other company persuing RNAi for
Huntington's Disease? It would be great if you write something
on this hopeful topic .. Thank You
12:52 AM, May 16, 2012
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